Literature DB >> 25267601

Gastroesophageal and extraesophageal reflux symptoms: similarities and differences.

Michael Drinnan1, Jason Powell, Ali Nikkar-Esfahani, Robert C Heading, Jill Doyle, S Michael Griffin, Paula Leslie, Paula T Bradley, Peter James, Janet A Wilson.   

Abstract

OBJECTIVES/HYPOTHESIS: The association between extraesophageal reflux (EER) and symptoms of gastroesophageal reflux disease (GERD) is inadequately understood. We used the Comprehensive Reflux Symptom Scale (CReSS) to evaluate EER and reflux-symptom prevalence in gastroenterology and otolaryngology outpatients and symptom awareness among UK gastroenterologists. STUDY
DESIGN: Cross-sectional cohort survey.
METHODS: Six hundred thirty-nine participants were surveyed: 103 controls, 359 patients undergoing esophagogastroduodenoscopy (EGD), and 177 otolaryngology clinic patients with throat symptoms. Participants completed the CReSS questionnaire. The study was undertaken in the Endoscopy Unit and the Department of Otolaryngology-Head and Neck Surgery, Newcastle upon Tyne Hospitals, Newcastle-upon-Tyne, United Kingdom. Registered members of the British Gastroenterology Society were asked to rate how frequently reflux patients might complain of each CReSS item.
RESULTS: The median CReSS total in volunteers (4) was significantly lower (P < .002) than in ear, nose, and throat (ENT) patients (26) or EGD patients with (42) or without (32) esophageal inflammation. All items were scored as ≥1 by >15% of ENT patients and 28% of EGD patients. Three major, robust CReSS factors: esophageal, pharyngeal, and upper airway emerged. Of 259 gastroenterologists, >20% scored 8 of the 34 symptoms as never being reported by reflux patients.
CONCLUSIONS: Endorsement of each EER CReSS item by 28% to 58% of patients with endoscopic evidence of GERD supports the Montreal consensus on an EER-GERD continuum. Gastroenterologists vary considerably in their appreciation of EER symptom relevance. The advantages of CReSS include standardized, comprehensive capture of patient experience; discriminant validity of ENT and GERD patients from volunteers; and discrete esophageal, pharyngeal, and upper airway subscales. LEVEL OF EVIDENCE: 4.
© 2014 The American Laryngological, Rhinological and Otological Society, Inc.

Entities:  

Keywords:  Gastroesophageal reflux; extraesophageal reflux; gastrointestinal; patient reported outcomes

Mesh:

Year:  2014        PMID: 25267601     DOI: 10.1002/lary.24950

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  5 in total

1.  Findings from a novel scintigraphic gastroesophageal reflux study in asymptomatic volunteers.

Authors:  Leticia Burton; Gregory Leighton Falk; John Beattie; Daniel Novakovic; Scott Simpson; Hans Van der Wall
Journal:  Am J Nucl Med Mol Imaging       Date:  2020-12-15

2.  The suitability of the GERDyzer instrument in pH-test-proven laryngopharyngeal reflux patients.

Authors:  Cheng-Pin Wu; Wen-Miin Liang; Chen-Chi Wang; Chi-Sen Chang; Hong-Zen Yeh; Jeng-Yuan Hsu; Chung-Wang Ko; Shou-Wu Lee; Shu-Chuan Chang; Fung-Chang Sung; Han-Chung Lien
Journal:  Medicine (Baltimore)       Date:  2016-08       Impact factor: 1.889

3.  Prevalence and clinical predictors of LPR among patients diagnosed with GERD according to the reflux symptom index questionnaire.

Authors:  Mahmoud Mosli; Bashaer Alkhathlan; Abdulmalik Abumohssin; Mazin Merdad; Ameen Alherabi; Osama Marglani; Hani Jawa; Talal Alkhatib; Hani Z Marzouki
Journal:  Saudi J Gastroenterol       Date:  2018 Jul-Aug       Impact factor: 2.485

4.  Evidence of Pepsin-Related Ocular Surface Damage and Dry Eye (PROD Syndrome) in Patients with Laryngopharyngeal Reflux.

Authors:  Rocco Plateroti; Marta Sacchetti; Giuseppe Magliulo; Andrea Maria Plateroti; Annalisa Pace; Antonietta Moramarco; Alessandro Lambiase; Alice Bruscolini
Journal:  Life (Basel)       Date:  2020-09-15

5.  'Persistent throat symptoms' versus 'laryngopharyngeal reflux': a cross-sectional study refining the clinical condition.

Authors:  James O'Hara; Holly Fisher; Louise Hayes; Janet Wilson
Journal:  BMJ Open Gastroenterol       Date:  2022-03
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.